An arbitrator has determined Prime Therapeutics violated federal and state antitrust laws against the AIDS Healthcare ...
Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback